search again

Urine Two-Gene Prostate Cancer Risk Test

Nationwide rates for HCPCS 0339U

Helps judge whether a man is likely to have prostate cancer serious enough to need a biopsy. The activity of two genes, HOXC6 and DLX1, is measured in a urine sample collected straight after a digital rectal examination, and the result is reported as a probability.

Rates data updated July 2026.

Facilitymedian $1,148 · 10th–90th $603$3,3880%20%10th90th$1,148Professionalmedian $617 · 10th–90th $316$1,1480%20%40%10th90th$617$0.0$0.2$2.0$20.0$200.0$2.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$602.56
Median
$1,202.26
Typical High
$3,162.28
Aetna
Setting
Professional
Modifier
Global
Typical Low
$457.09
Median
$602.56
Typical High
$870.96
BCBS
Setting
Facility
Modifier
Global
Typical Low
$645.65
Median
$1,513.56
Typical High
$3,801.89
BCBS
Setting
Professional
Modifier
Global
Typical Low
$302.00
Median
$354.81
Typical High
$1,096.48
Cigna
Setting
Facility
Modifier
Global
Typical Low
$524.81
Median
$1,513.56
Typical High
$3,388.44
Cigna
Setting
Professional
Modifier
Global
Typical Low
$891.25
Median
$1,122.02
Typical High
$2,089.30
United
Setting
Facility
Modifier
Global
Typical Low
$316.23
Median
$758.58
Typical High
$912.01
United
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$954.99